Sean Moran's Stock Transactions in Corbus Pharmaceuticals Holdings, Inc.

On October 24, 2025, Sean Moran, the Chief Financial Officer of Corbus Pharmaceuticals Holdings, Inc., engaged in several stock transactions. Moran acquired 12,981 shares of common stock at $4.26 per share, increasing his total holdings to 86,294 shares. On the same day, he sold 12,981 shares at a weighted average price of $17.02 per share, reducing his holdings to 73,313 shares. Additionally, Moran exercised stock options to buy 12,981 shares of common stock at $4.26 per share, resulting in a post-transaction holding of 10,386 stock options. These transactions were executed under a Rule 10b5-1 trading plan, which Moran adopted on March 14, 2025.